Vitamins and Minerals in Health

Vitamins are organic compounds that the human body requires in small amounts for normal physiological function. They differ from macronutrients such as carbohydrates, proteins, and fats because they do not provide energy but act as catalysts, regulators, or structural components in metabolic pathways. The term essential nutrient signifies that a vitamin must be obtained from the diet because the body cannot synthesize it in sufficient quantities. Vitamins are classified by their solubility: fat‑soluble vitamins (A, D, E, and K) are stored in adipose tissue and the liver, while water‑soluble vitamins (the B‑complex and vitamin C) circulate freely in the bloodstream and excess amounts are excreted in urine. Understanding the distinct properties of each class is critical for assessing dietary adequacy, planning supplementation, and managing potential toxicity.

Vitamin A refers to a group of compounds that include retinol, retinal, retinoic acid, and provitamin A carotenoids such as β‑carotene. Retinol is the active form that participates in vision, immune function, and epithelial cell maintenance. Retinal is essential for the phototransduction cascade in the retina, where it combines with opsin proteins to form rhodopsin. Retinoic acid functions as a transcriptional regulator, influencing gene expression during embryonic development and cellular differentiation. Provitamin A carotenoids are converted to retinol in the intestine, a process regulated by the enzyme β‑carotene 15,15′‑dioxygenase. Dietary sources of preformed vitamin A include liver, fish oils, and dairy products, whereas provitamin A is abundant in orange and dark‑green vegetables such as carrots, sweet potatoes, and kale. Deficiency manifests as night blindness, xerophthalmia, and increased susceptibility to infection. Toxicity, known as hypervitaminosis A, can cause hepatotoxicity, teratogenic effects, and intracranial hypertension; it typically results from chronic intake of high‑dose supplements rather than food sources.

Vitamin D encompasses two major forms: Vitamin D₂ (ergocalciferol) derived from plant sterols, and vitamin D₃ (cholecalciferol) synthesized in human skin upon exposure to ultraviolet‑B (UV‑B) radiation. Both forms undergo hydroxylation in the liver to form 25‑hydroxyvitamin D (calcidiol), the principal circulating metabolite used to assess status. A second hydroxylation step in the kidney generates the biologically active hormone 1,25‑dihydroxyvitamin D (calcitriol). Calcitriol binds to the nuclear vitamin D receptor (VDR), regulating calcium and phosphate homeostasis through increased intestinal absorption, renal reabsorption, and bone remodeling. Adequate vitamin D status supports bone mineralization, reduces risk of rickets in children, and osteomalacia in adults. Emerging evidence links vitamin D to immune modulation, cardiovascular health, and cancer risk reduction. Deficiency is common in populations with limited sun exposure, high melanin pigmentation, or malabsorption syndromes. Excess intake, especially of synthetic D₃ supplements, can lead to hypercalcemia, nephrocalcinosis, and vascular calcification.

Vitamin E is a collective term for a family of eight tocopherols and tocotrienols, each possessing a chromanol ring and a hydrophobic side chain. Α‑Tocopherol is the most biologically active form in humans, preferentially retained by the hepatic α‑tocopherol transfer protein (α‑TTP). Vitamin E functions primarily as a lipid‑soluble antioxidant, terminating free‑radical chain reactions in cell membranes and lipoproteins. By protecting polyunsaturated fatty acids from peroxidation, it preserves membrane integrity and prevents oxidative damage to lipoproteins, which is crucial for cardiovascular health. Dietary sources include vegetable oils, nuts, seeds, and leafy greens. Deficiency, though rare, manifests as hemolytic anemia, peripheral neuropathy, and muscle degeneration, often observed in patients with fat‑malabsorption disorders. High‑dose supplementation may increase the risk of hemorrhagic stroke due to interference with platelet aggregation, highlighting the importance of adhering to established tolerable upper intake levels (UL).

Vitamin K comprises a group of structurally related compounds, the most common being phylloquinone (vitamin K₁) from plant chlorophyll and menaquinones (vitamin K₂) synthesized by gut bacteria. Vitamin K serves as a cofactor for the γ‑carboxylase enzyme, which converts specific glutamic acid residues in clotting factors II, VII, IX, and X, as well as proteins C and S, to γ‑carboxyglutamate. This modification enables calcium binding, a prerequisite for proper clot formation and bone mineralization. Dietary sources of K₁ include green leafy vegetables such as spinach, kale, and broccoli, whereas K₂ is found in fermented foods like natto and certain animal products. Deficiency leads to prolonged prothrombin time, increased bleeding tendency, and skeletal abnormalities. Warfarin therapy antagonizes vitamin K recycling, necessitating careful monitoring of dietary intake to avoid adverse interactions.

Vitamin C (ascorbic acid) is a water‑soluble antioxidant that participates in collagen synthesis, neurotransmitter production, and iron absorption. It donates electrons to neutralize reactive oxygen species (ROS) and regenerates other antioxidants such as vitamin E. In the hydroxylation of proline and lysine residues during collagen formation, vitamin C is indispensable for maintaining the structural integrity of skin, blood vessels, and connective tissue. Its role in enhancing non‑heme iron absorption is particularly important for individuals relying on plant‑based diets. Rich sources include citrus fruits, berries, kiwi, bell peppers, and cruciferous vegetables. Deficiency, known as scurvy, presents with gum bleeding, joint pain, and impaired wound healing. Because excess vitamin C is readily excreted, toxicity is rare, though megadoses may cause gastrointestinal upset and increase oxalate stone risk in susceptible individuals.

The B‑complex vitamins consist of eight distinct water‑soluble compounds, each serving as a coenzyme or precursor for enzymatic reactions in energy metabolism, nucleic acid synthesis, and neuronal function. Their collective importance lies in converting macronutrients into adenosine triphosphate (ATP) and supporting the synthesis of neurotransmitters and red blood cells.

Thiamine (B₁) is phosphorylated to thiamine pyrophosphate (TPP), an essential cofactor for the decarboxylation of pyruvate to acetyl‑CoA and for the transketolase reaction in the pentose phosphate pathway. Adequate thiamine status is required for glucose metabolism, particularly in the nervous system and cardiac muscle. Sources include whole grains, legumes, pork, and fortified cereals. Deficiency, termed beriberi, manifests as peripheral neuropathy, muscle weakness, and high‑output cardiac failure. Chronic alcoholism interferes with thiamine absorption and storage, increasing risk.

Riboflavin (B₂) is converted to flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), which function as redox carriers in the electron transport chain and in the metabolism of fatty acids, amino acids, and other vitamins (e.G., Conversion of B₆ to pyridoxal phosphate). Dairy products, eggs, lean meats, and green vegetables provide riboflavin. Deficiency can cause cheilosis, glossitis, and seborrheic dermatitis.

Niacin (B₃) exists as nicotinic acid and nicotinamide, precursors to nicotinamide adenine dinucleotide (NAD⁺) and NAD phosphate (NADP⁺). These coenzymes are central to oxidation‑reduction reactions, DNA repair, and cell signaling pathways. Dietary sources include meat, fish, poultry, and legumes, as well as tryptophan‑rich foods that can be converted to niacin. Pellagra, the classic deficiency disease, is characterized by the “three D’s”: Dermatitis, diarrhea, and dementia. Severe deficiency can be fatal if untreated.

Pyridoxine (B₆) is transformed into pyridoxal phosphate (PLP), a versatile coenzyme involved in amino acid transamination, decarboxylation, and glycogenolysis. PLP also participates in the synthesis of neurotransmitters such as serotonin, dopamine, and γ‑aminobutyric acid (GABA). Sources include fish, poultry, potatoes, and bananas. Deficiency may lead to microcytic anemia, peripheral neuropathy, and convulsions.

Biotin (B₇) functions as a covalently attached cofactor for carboxylases that catalyze key steps in gluconeogenesis, fatty‑acid synthesis, and amino‑acid catabolism. It is abundant in egg yolk, organ meats, nuts, and legumes. Biotin deficiency is rare but can cause dermatitis, alopecia, and metabolic disturbances.

Folates (B₉) encompass tetrahydrofolate (THF) derivatives that donate one‑carbon units for nucleic‑acid synthesis, methylation reactions, and amino‑acid metabolism. Folate is crucial for DNA replication and repair, making it especially important during periods of rapid cell division such as pregnancy. Dietary sources include leafy greens, legumes, and fortified grains. Insufficient folate leads to megaloblastic anemia and, in pregnant women, increased risk of neural‑tube defects in the fetus. Folate status is assessed by measuring serum folate and red‑cell folate concentrations.

Vitamin B₁₂ (cobalamin) contains a corrin ring with a central cobalt atom and is required for the conversion of methylmalonyl‑CoA to succinyl‑CoA and for the remethylation of homocysteine to methionine. These reactions are essential for fatty‑acid metabolism and for DNA synthesis. Vitamin B₁₂ is synthesized by microorganisms and obtained primarily from animal‑derived foods such as meat, fish, dairy, and eggs. Deficiency results in pernicious anemia, neurological deficits, and elevated homocysteine levels, a risk factor for cardiovascular disease. Absorption depends on intrinsic factor secreted by gastric parietal cells; disorders that impair intrinsic factor production (e.G., Autoimmune gastritis) can cause B₁₂ malabsorption.

The term cofactor refers to a non‑protein chemical compound that is required for an enzyme’s catalytic activity. Cofactors may be inorganic ions (e.G., Zn²⁺, Fe²⁺) or organic molecules (coenzymes) such as the vitamins described above. When a vitamin functions as a coenzyme, it often undergoes reversible chemical changes during the catalytic cycle and is regenerated at the end of the reaction. Understanding which vitamins act as cofactors for specific enzymes enables clinicians to predict the metabolic consequences of deficiencies and to design targeted supplementation strategies.

Minerals are inorganic elements required for a multitude of physiological processes, ranging from structural roles in bone to catalytic functions in enzymatic reactions. They are categorized by the quantities needed: macrominerals (required in gram quantities) and trace minerals (required in milligram or microgram quantities). Both groups are essential for health, and imbalances can have profound clinical implications.

Calcium is the most abundant mineral in the human body, comprising 99 % of total body stores in bone and teeth. It provides structural rigidity, participates in muscle contraction, nerve transmission, and blood clotting, and acts as a second messenger in intracellular signaling pathways. Calcium homeostasis is tightly regulated by parathyroid hormone (PTH), calcitonin, and active vitamin D. Dietary calcium is abundant in dairy products, fortified plant milks, leafy greens, and certain fish with edible bones. Adequate intake is essential for peak bone mass acquisition in adolescence and for maintenance of bone density in adulthood. Deficiency can lead to osteopenia, osteoporosis, and increased fracture risk, while hypercalcemia may cause nephrolithiasis, arrhythmias, and neuropsychiatric disturbances.

Phosphorus is present mainly as phosphate ions, which combine with calcium to form hydroxyapatite crystals in bone. Phosphate is also a critical component of nucleic acids, ATP, and cell membranes (phospholipids). The majority of dietary phosphorus comes from protein‑rich foods such as meat, dairy, nuts, and legumes. The kidneys regulate phosphate excretion in response to PTH and fibroblast growth factor‑23 (FGF‑23). Deficiency is uncommon but can cause impaired bone mineralization, weakness, and respiratory failure. Excess phosphorus, particularly from inorganic phosphate additives, may promote secondary hyperparathyroidism and vascular calcification in patients with chronic kidney disease.

Magnesium serves as a cofactor for over 300 enzymatic reactions, including those involved in ATP synthesis, DNA replication, and protein synthesis. It stabilizes ribosomal structures, influences neuromuscular excitability, and contributes to bone mineral density. Dietary sources include nuts, seeds, whole grains, legumes, and green leafy vegetables. Magnesium deficiency can manifest as muscle cramps, arrhythmias, and increased risk of type 2 diabetes. Excess intake from supplements may cause diarrhea and, in severe cases, hypermagnesemia leading to hypotension and respiratory depression.

Potassium is the principal intracellular cation, essential for maintaining cellular membrane potential, nerve impulse conduction, and muscle contraction, including cardiac rhythm. It also modulates renal sodium handling and thus influences blood pressure. Foods rich in potassium include fruits (bananas, oranges), vegetables (potatoes, spinach), legumes, and dairy. Hypokalemia can cause weakness, arrhythmias, and metabolic alkalosis, while hyperkalemia is a medical emergency that can precipitate life‑threatening cardiac arrhythmias.

Sodium is the main extracellular cation, pivotal for fluid balance, nerve transmission, and muscle function. The body tightly regulates sodium through renal excretion, guided by aldosterone and atrial natriuretic peptide. Dietary sodium is primarily derived from salt (NaCl) added during cooking or processing. Excess sodium intake is linked to hypertension, stroke, and cardiovascular disease. Sodium deficiency (hyponatremia) can cause cerebral edema, seizures, and coma, especially in conditions of excessive water intake or diuretic use.

Chloride functions alongside sodium to maintain osmotic balance and gastric acidity (hydrochloric acid). It is also a constituent of many extracellular fluids. Sources are similar to sodium, as most table salt is sodium chloride. Imbalances are usually secondary to disturbances in sodium or acid‑base status.

Iron is a trace mineral critical for oxygen transport, electron transfer, and DNA synthesis. It exists in two oxidation states: Ferrous (Fe²⁺) and ferric (Fe³⁺). Hemoglobin and myoglobin contain heme‑bound iron, while numerous enzymes utilize non‑heme iron. Dietary iron is supplied as heme iron from animal sources (meat, fish, poultry) and non‑heme iron from plant foods (legumes, fortified cereals, leafy greens). Heme iron is more efficiently absorbed via a transporter that bypasses the regulatory step of reduction, whereas non‑heme iron requires reduction to Fe²⁺ by duodenal cytochrome b (Dcytb) before transport via divalent metal transporter‑1 (DMT‑1). Iron status is tightly controlled by the hormone hepcidin, which modulates ferroportin activity on enterocytes and macrophages. Iron deficiency is the leading cause of anemia worldwide, presenting with fatigue, pallor, and reduced cognitive performance. Iron overload disorders, such as hereditary hemochromatosis, lead to hepatic, cardiac, and pancreatic damage due to oxidative stress.

Zinc is a trace element that serves as a structural component of over 300 enzymes, including DNA polymerases, RNA polymerases, and carbonic anhydrase. It also stabilizes protein domains (zinc fingers) involved in transcriptional regulation. Zinc participates in immune function, wound healing, taste perception, and growth. Dietary sources encompass meat, shellfish (especially oysters), legumes, nuts, and whole grains. Zinc absorption occurs primarily in the small intestine via ZIP4 transporters and is regulated by metallothionein, which can bind excess zinc and other metals. Deficiency presents with growth retardation, impaired immunity, alopecia, and dermatitis. Excess zinc can interfere with copper absorption, leading to secondary copper deficiency and associated anemia and neutropenia.

Copper is essential for the activity of enzymes such as cytochrome c oxidase, superoxide dismutase (Cu‑Zn SOD), and lysyl oxidase. These enzymes are involved in oxidative phosphorylation, antioxidant defense, and collagen cross‑linking, respectively. Copper is absorbed in the stomach and duodenum via the copper transporter 1 (CTR1) and is bound to ceruloplasmin for transport in plasma. Food sources include organ meats, shellfish, nuts, seeds, and whole grains. Copper deficiency can cause anemia, neutropenia, bone abnormalities, and neurological symptoms. Wilson’s disease, a genetic disorder of copper metabolism, leads to toxic copper accumulation in liver and brain, requiring chelation therapy.

Manganese functions as a cofactor for enzymes such as mitochondrial superoxide dismutase (Mn‑SOD), arginase, and glutamine synthetase. It is involved in carbohydrate metabolism, bone formation, and antioxidant defenses. Manganese is present in whole grains, nuts, legumes, and tea. Deficiency is rare but may impair growth and glucose tolerance. Excess manganese exposure, particularly inhalation in occupational settings, can cause neurotoxicity resembling Parkinsonian disorder.

Selenium is incorporated into selenoproteins, the most notable being glutathione peroxidases (GPx) and iodothyronine deiodinases. GPx enzymes reduce hydrogen peroxide and lipid hydroperoxides, protecting cells from oxidative damage. Deiodinases convert thyroxine (T₄) to the active thyroid hormone triiodothyronine (T₃). Selenium is abundant in Brazil nuts, seafood, organ meats, and cereals. Deficiency can manifest as Keshan disease (a cardiomyopathy) and Kashin‑Beck disease (an osteoarthropathy). Selenium toxicity (selenosis) results in hair loss, nail brittleness, and neurologic disturbances; it is usually linked to excessive supplementation.

Iodine is a trace element required for the synthesis of thyroid hormones thyroxine (T₄) and triiodothyronine (T₃). Adequate iodine intake ensures proper metabolic rate, neurodevelopment, and reproductive health. Iodine is obtained primarily from iodized salt, seaweed, dairy, and certain fish. Deficiency leads to goiter, hypothyroidism, and in pregnant women, cretinism in the offspring. Excess iodine can precipitate hyperthyroidism (Jod‑Basedow phenomenon) or hypothyroidism (Wolff‑Chaikoff effect), particularly in individuals with underlying thyroid disease.

Chromium enhances insulin signaling by facilitating the activation of the insulin receptor and downstream pathways, thereby influencing glucose metabolism. It is present in whole grains, meat, fruits, and vegetables. Chromium deficiency is associated with impaired glucose tolerance, while supplementation may improve glycemic control in some individuals with type 2 diabetes, though evidence remains mixed.

Molybdenum serves as a cofactor for enzymes such as xanthine oxidase, aldehyde oxidase, and sulfite oxidase, which are involved in purine catabolism and detoxification of sulfite. Dietary sources include legumes, grains, and nuts. Deficiency is extremely rare and usually only observed in patients receiving total parenteral nutrition without molybdenum supplementation.

Fluoride is incorporated into hydroxyapatite crystals to form fluorapatite, increasing enamel resistance to acid demineralization and thereby reducing dental caries. It is commonly delivered via fluoridated water, toothpaste, and professional applications. Excessive fluoride intake can cause dental fluorosis (enamel mottling) and skeletal fluorosis (joint pain, stiffness).

The concept of bioavailability describes the proportion of an ingested nutrient that is absorbed and becomes available for physiological function. Bioavailability is influenced by the chemical form of the nutrient, presence of enhancers (e.G., Vitamin C for non‑heme iron), inhibitors (e.G., Phytate, oxalate, polyphenols), food matrix, and individual factors such as age, health status, and genetics. For example, the bioavailability of calcium from dairy is higher than that from certain leafy greens because oxalates in the latter bind calcium and reduce absorption.

The term RDA (Recommended Dietary Allowance) denotes the average daily intake level sufficient to meet the nutrient requirements of nearly all (97‑98 %) healthy individuals in a specific life‑stage group. It is derived from the Estimated Average Requirement (EAR) and includes a safety margin. The UL (Tolerable Upper Intake Level) represents the maximum daily intake unlikely to cause adverse health effects. Both RDA and UL values guide nutrition professionals in assessing adequacy and preventing excess.

Nutrient interaction concepts such as synergy and antagonism are critical when formulating supplement regimens. Synergy occurs when two nutrients enhance each other’s absorption or function; classic examples include vitamin C enhancing non‑heme iron absorption and the combination of calcium and vitamin D facilitating bone mineralization. Antagonism refers to a situation where one nutrient impairs the absorption or utilization of another, such as high zinc intake reducing copper absorption or excessive calcium interfering with iron uptake.

Fortification and enrichment are public‑health strategies used to improve population nutrient status. Fortification adds nutrients to foods that do not naturally contain them (e.G., Adding vitamin D to milk), while enrichment restores nutrients lost during processing (e.G., Iron‑enriched flour). These approaches have successfully reduced deficiencies of iodine, folate, and vitamin D in many regions, but they also require careful monitoring to avoid exceeding ULs.

When evaluating supplement products, several key vocabulary items are essential. Label claim refers to statements on the packaging that describe a product’s intended benefit (e.G., “Supports immune health”). Dosage form describes the physical presentation of the supplement (tablet, capsule, liquid, powder). Standardization indicates that a product contains a defined amount of a specific active ingredient (e.G., “Standardized to 20 % curcuminoids”). Bioequivalence compares the absorption profile of a generic product to that of a reference product. Good Manufacturing Practice (GMP) compliance assures that the product has been produced under quality‑controlled conditions.

Regulatory terminology varies across jurisdictions. In the United States, the Food and Drug Administration (FDA) classifies dietary supplements under the Dietary Supplement Health and Education Act (DSHEA) as a subcategory of food, not drugs. Consequently, manufacturers are responsible for ensuring safety and labeling accuracy, while the FDA can take action against adulterated or misbranded products. In the European Union, supplements are regulated as “food supplements” under the Nutrition and Health Claims Regulation, requiring scientific substantiation for any health claim. Understanding these regulatory frameworks aids professionals in navigating product development, marketing, and compliance.

Clinical assessment of vitamin and mineral status employs several laboratory methods. Serum concentrations are commonly used for water‑soluble vitamins (e.G., Vitamin B₁₂, folate) and for minerals such as calcium, magnesium, and zinc. For fat‑soluble vitamins, plasma or serum levels of retinol, 25‑hydroxyvitamin D, and α‑tocopherol are measured. Functional biomarkers provide insight into nutrient activity, such as measuring erythrocyte glutathione peroxidase activity for selenium status or homocysteine levels for folate and B₁₂ adequacy. Bone health is evaluated through dual‑energy X‑ray absorptiometry (DXA) scans to assess mineral density, a downstream indicator of calcium, vitamin D, and vitamin K sufficiency.

Challenges in achieving optimal vitamin and mineral intake arise from dietary patterns, life‑stage demands, health conditions, and socioeconomic factors. For instance, individuals following vegan diets may be at risk for vitamin B₁₂, iron (heme), calcium, zinc, and iodine deficiencies, necessitating careful food selection or fortified products. Elderly populations often experience reduced gastric acid secretion, impairing absorption of vitamin B₁₂ and calcium, while also facing increased risk of osteoporosis due to declining estrogen levels. Athletes may have higher requirements for electrolytes (sodium, potassium, magnesium) due to sweat losses, as well as increased iron turnover from hemolysis. Chronic diseases such as inflammatory bowel disease, celiac disease, and chronic kidney disease alter nutrient absorption, metabolism, and excretion, requiring individualized supplementation plans.

Food‑based strategies to enhance nutrient intake include increasing consumption of nutrient‑dense foods, employing culinary techniques that reduce antinutrient content (e.G., Soaking, fermenting, sprouting to lower phytate levels), and pairing foods to promote synergistic absorption (e.G., Adding lemon juice to iron‑rich beans). In clinical practice, when food alone cannot meet needs, evidence‑based supplementation is employed. The selection of a supplement should consider the appropriate form (e.G., Calcium carbonate vs. Calcium citrate), dosage, timing (with meals or on an empty stomach), and potential interactions with medications (e.G., Bisphosphonates, anticoagulants, thyroid hormone replacement). Monitoring for adverse effects, such as gastrointestinal irritation from high‑dose vitamin C or constipation from iron tablets, is essential.

Adverse reactions to micronutrient supplementation can be categorized as acute toxicity, chronic toxicity, and hypersensitivity. Acute toxicity often results from accidental overdose (e.G., Accidental ingestion of a high‑concentration vitamin D supplement), leading to rapid onset of symptoms such as hypercalcemia, nausea, and vomiting. Chronic toxicity develops over prolonged excessive intake and may manifest as organ damage (e.G., Liver injury from chronic high‑dose vitamin A). Hypersensitivity reactions, though uncommon, can occur with certain mineral preparations (e.G., Nickel allergy from zinc supplements). Recognizing the signs of toxicity and understanding the therapeutic window for each micronutrient are vital for safe practice.

Pharmacokinetic concepts applied to vitamins and minerals include absorption, distribution, metabolism, and excretion (ADME). For example, vitamin D undergoes hepatic 25‑hydroxylation followed by renal 1α‑hydroxylation, and its metabolites are bound to vitamin D‑binding protein for transport. Minerals such as iron are stored bound to ferritin, released via ferroportin, and recycled through the reticuloendothelial system. The half‑life of water‑soluble vitamins is generally short (e.G., Vitamin B₆ has a plasma half‑life of 15–20 minutes), whereas fat‑soluble vitamins have longer half‑lives due to tissue storage (vitamin A can have a half‑life of several months). These kinetic properties influence dosing frequency and the risk of accumulation.

The concept of nutrient density describes the concentration of essential nutrients per unit of energy in a food. Foods with high nutrient density provide a greater amount of vitamins and minerals relative to calories, such as leafy greens, legumes, and fish. Promoting nutrient‑dense foods aligns with dietary guidelines aimed at preventing micronutrient deficiencies while managing caloric intake.

In research contexts, the term biomarker refers to a measurable indicator of a biological state or condition. Micronutrient biomarkers are used to evaluate the impact of interventions, monitor population health, and establish reference ranges. For example, serum ferritin serves as a marker of iron stores, while plasma vitamin C concentrations reflect recent intake due to its rapid turnover. Selecting appropriate biomarkers requires consideration of sensitivity, specificity, and the influence of inflammation or infection on the measurement.

The use of functional foods blends nutrition and health claims, often incorporating added vitamins or minerals to confer specific benefits. Examples include probiotic yogurts fortified with vitamin D, or breakfast cereals enriched with iron and folic acid. Functional foods must meet regulatory criteria for safety and substantiation of claimed effects, and they offer a vehicle for improving micronutrient intake in populations with limited access to diverse diets.

Finally, the practice of personalized nutrition acknowledges genetic variations that affect micronutrient metabolism. Polymorphisms in genes such as MTHFR (methylenetetrahydrofolate reductase) can influence folate utilization and homocysteine levels, prompting individualized recommendations for folic acid dosage. Similarly, variations in the CYP2R1 gene affect vitamin D activation, potentially necessitating higher supplementation doses for certain individuals. Emerging technologies in nutrigenomics aim to integrate genetic data with dietary assessment to tailor vitamin and mineral recommendations for optimal health outcomes.